Rejuvenation Technologies Inc. Patents

Patent portfolio assigned to Rejuvenation Technologies Inc. (verified via public assignee records). Preclinical longevity biotech developing telomerase (TERT) mRNA-LNP therapeutics (YC, Khosla-backed); no commercial customers. Has filed multiple patent applications via Cognition IP (case study confirms 1st/2nd/3rd applications); founder's foundational TERT-mRNA telomere work also patented by Stanford. Exact assignee patent count not visible. No direct competitors confidently identified.